Ptc Therapeutics, Inc. · NASDAQ:PTCT

Boulding Mark Elliott sold 2,265 Ptc Therapeutics, Inc. shares (Form 4)

Traded Apr 6, 2026 · Filed Apr 8, 2026

On Apr 6, 2026, Boulding Mark Elliott (EXEC. VP AND CLO) sold 2,265 Ptc Therapeutics, Inc. shares at an average US$69.45 for US$157K under a trading plan, leaving 105,212 shares. Filed Apr 8, 2026 (Form 4).

Sold
2,265 shares
Price
US$69.45 average (US$68.91 to US$69.75)
Value
US$157K
Holding after
105,212 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EXEC. VP AND CLO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 6, 2026Common StockOption exercise2,265US$39.42107,477Direct
Apr 6, 2026Common StockSale822US$68.91106,655Direct
Apr 6, 2026Common StockSale1,443US$69.75105,212Direct

Source

View original at SEC

Related